SurModics (SRDX) Names Andy LaFrence as CFO

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industries, today announced the appointment of Andy LaFrence as the company’s Vice President of Finance and Chief Financial Officer, effective February 12, 2013. He will lead all of the financial activities of SurModics, including controlling, financial planning and analysis, treasury, tax, audit and investor relations. LaFrence will succeed Timothy Arens, who currently serves as interim Chief Financial Officer. Arens will remain with the company and will transition into the role of Vice President of Corporate Development and Strategy. In his new role, Mr. Arens will lead the company’s efforts in developing strategies and assessing growth opportunities for its Medical Device and In Vitro Diagnostics businesses.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• SandRidge (SD) CEO Ward Resigns, James Bennett to Assume Role
• Semiconductor Manufacturing (SMI) Appoints Sean Maloney as Indep. Director
• Duke Energy (DUK) Names Lynn Good as CEO

Create E-mail Alert Related Categories

Management Changes

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?